The present invention describes difluororthioacetamide oxazolidinones with a glycoloylpiperazine substituent as novel antibacterial agents, and antimicrobial combination therapies for combating infective diseases caused by gram-positive and gram-negative bacteria.
本发明描述了具有甘
氨酰
哌嗪取代基的二
氟硫代乙酰胺
噁唑啉作为新型抗菌剂,以及用于对抗由革兰氏阳性和革兰氏阴性细菌引起的感染性疾病的抗微
生物组合疗法。